ANAPTYSBIO, INC. Diluted Shares Outstanding (Weighted Average)
ANAPTYSBIO, INC. (ANAB) reported Diluted Shares Outstanding (Weighted Average) of 37.48 million shares for the 6-month period ending 2026-06-30, per its 10-KT filed 2026-09-21.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-21
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 46.26M shares, a 60.57% increase year-over-year.
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 28.69M shares, a 6.37% decline year-over-year.
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 33.68M shares, a 4.09% decline year-over-year.
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 29.02M shares, a 0.43% increase year-over-year.
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 30.23M shares, a 2.33% increase from fiscal 2024.
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 29.54M shares, a 9.73% increase from fiscal 2023.
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 26.92M shares, a 4.41% decline from fiscal 2022.
- ANAPTYSBIO, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 28.16M shares, a 2.68% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 46.26M shares derived: 10-KT 6 month − 10-Q 3 month · filed 2026-09-21 | 37.48M shares 10-KT · filed 2026-09-21 | 36.21M shares derived: average of 3 quarters · filed 2026-09-21 | 34.41M shares derived: average of 4 quarters · filed 2026-09-21 | ||
| 2026-03-31 | 28.69M shares 10-Q · filed 2026-05-12 | 31.18M shares derived: average of 2 quarters · filed 2026-09-21 | 30.46M shares derived: average of 3 quarters · filed 2026-09-21 | 30.05M shares derived: average of 4 quarters · filed 2026-09-21 | ||
| 2025-12-31 | 33.68M shares derived: 10-KT 12 month − 10-Q 9 month · filed 2026-09-21 | 31.35M shares derived: average of 2 quarters · filed 2026-09-21 | 30.50M shares derived: average of 3 quarters · filed 2026-09-21 | 30.23M shares 10-KT · filed 2026-09-21 | 28.76M shares 10-K · filed 2026-03-03 | |
| 2025-09-30 | 29.02M shares 10-Q · filed 2025-11-04 | 28.91M shares derived: average of 2 quarters · filed 2025-11-04 | 29.09M shares 10-Q · filed 2025-11-04 | 30.90M shares derived: average of 4 quarters · filed 2026-09-21 | ||
| 2025-06-30 | 28.81M shares 10-Q · filed 2025-08-06 | 30.69M shares 10-KT · filed 2026-09-21 | 29.72M shares 10-Q · filed 2025-08-06 | 31.52M shares derived: average of 3 quarters · filed 2026-09-21 | 30.86M shares derived: average of 4 quarters · filed 2026-09-21 | |
| 2025-03-31 | 30.64M shares 10-Q · filed 2026-05-12 | 32.88M shares derived: average of 2 quarters · filed 2026-09-21 | 31.55M shares derived: average of 3 quarters · filed 2026-09-21 | 30.50M shares derived: average of 4 quarters · filed 2026-09-21 | ||
| 2024-12-31 | 35.11M shares derived: 10-KT 12 month − 10-Q 9 month · filed 2026-09-21 | 32.00M shares derived: average of 2 quarters · filed 2026-09-21 | 30.45M shares derived: average of 3 quarters · filed 2026-09-21 | 29.54M shares 10-KT · filed 2026-09-21 | 28.38M shares 10-K · filed 2025-02-27 | |
| 2024-09-30 | 28.89M shares 10-Q · filed 2025-11-04 | 28.12M shares derived: average of 2 quarters · filed 2025-11-04 | 27.69M shares 10-Q · filed 2025-11-04 | 27.41M shares derived: average of 4 quarters · filed 2026-03-03 | ||
| 2024-06-30 | 27.36M shares 10-Q · filed 2025-08-06 | 27.08M shares 10-Q · filed 2025-08-06 | 26.91M shares derived: average of 3 quarters · filed 2026-03-03 | 26.82M shares derived: average of 4 quarters · filed 2026-03-03 | ||
| 2024-03-31 | 26.80M shares 10-Q · filed 2025-05-05 | 26.69M shares derived: average of 2 quarters · filed 2026-03-03 | 26.64M shares derived: average of 3 quarters · filed 2026-03-03 | 26.64M shares derived: average of 4 quarters · filed 2026-03-03 | ||
| 2023-12-31 | 26.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 26.56M shares derived: average of 2 quarters · filed 2026-03-03 | 26.59M shares derived: average of 3 quarters · filed 2026-03-03 | 26.92M shares 10-K · filed 2026-03-03 | ||
| 2023-09-30 | 26.55M shares 10-Q · filed 2024-11-05 | 26.59M shares derived: average of 2 quarters · filed 2024-11-05 | 27.04M shares 10-Q · filed 2024-11-05 | 27.39M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | 26.63M shares 10-Q · filed 2024-08-05 | 27.29M shares 10-Q · filed 2024-08-05 | 27.68M shares derived: average of 3 quarters · filed 2025-02-27 | 27.83M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | 27.95M shares 10-Q · filed 2024-05-09 | 28.20M shares derived: average of 2 quarters · filed 2025-02-27 | 28.23M shares derived: average of 3 quarters · filed 2025-02-27 | 28.22M shares derived: average of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | 28.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 28.37M shares derived: average of 2 quarters · filed 2025-02-27 | 28.31M shares derived: average of 3 quarters · filed 2025-02-27 | 28.16M shares 10-K · filed 2025-02-27 | ||
| 2022-09-30 | 28.29M shares 10-Q · filed 2023-11-02 | 28.25M shares derived: average of 2 quarters · filed 2023-11-02 | 28.07M shares 10-Q · filed 2023-11-02 | 27.93M shares derived: average of 4 quarters · filed 2024-03-11 | ||
| 2022-06-30 | 28.20M shares 10-Q · filed 2023-08-07 | 27.96M shares 10-Q · filed 2023-08-07 | 27.82M shares derived: average of 3 quarters · filed 2024-03-11 | 27.72M shares derived: average of 4 quarters · filed 2024-03-11 | ||
| 2022-03-31 | 27.71M shares 10-Q · filed 2023-05-11 | 27.62M shares derived: average of 2 quarters · filed 2024-03-11 | 27.56M shares derived: average of 3 quarters · filed 2024-03-11 | 27.52M shares derived: average of 4 quarters · filed 2024-03-11 | ||
| 2021-12-31 | 27.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 27.48M shares derived: average of 2 quarters · filed 2024-03-11 | 27.45M shares derived: average of 3 quarters · filed 2024-03-11 | 27.43M shares 10-K · filed 2024-03-11 | ||
| 2021-09-30 | 27.44M shares 10-Q · filed 2022-11-08 | 27.41M shares derived: average of 2 quarters · filed 2022-11-08 | 27.40M shares 10-Q · filed 2022-11-08 | 27.38M shares derived: average of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | 27.39M shares 10-Q · filed 2022-08-08 | 27.38M shares 10-Q · filed 2022-08-08 | 27.37M shares derived: average of 3 quarters · filed 2023-03-01 | 27.35M shares derived: average of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | 27.36M shares 10-Q · filed 2022-05-04 | 27.36M shares derived: average of 2 quarters · filed 2023-03-01 | 27.34M shares derived: average of 3 quarters · filed 2023-03-01 | 27.33M shares derived: average of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | 27.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 27.33M shares derived: average of 2 quarters · filed 2023-03-01 | 27.32M shares derived: average of 3 quarters · filed 2023-03-01 | 27.30M shares 10-K · filed 2023-03-01 | ||
| 2020-09-30 | 27.32M shares 10-Q · filed 2021-11-04 | 27.30M shares derived: average of 2 quarters · filed 2021-11-04 | 27.29M shares 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | 27.28M shares 10-Q · filed 2021-08-09 | 27.27M shares 10-Q · filed 2021-08-09 | ||||
| 2019-12-31 | 27.06M shares 10-K · filed 2022-03-07 | |||||
| 2017-09-30 | 20.38M shares 10-Q · filed 2017-11-07 | 20.33M shares derived: average of 2 quarters · filed 2017-11-07 | 18.67M shares 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | 20.27M shares 10-Q · filed 2017-08-10 | 17.80M shares 10-Q · filed 2017-08-10 | ||||
| 2016-09-30 | 2.64M shares 10-Q · filed 2017-11-07 | 3.07M shares derived: average of 2 quarters · filed 2017-11-07 | 3.47M shares 10-Q · filed 2017-11-07 | |||
| 2016-06-30 | 3.50M shares 10-Q · filed 2017-08-10 | 3.50M shares 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |